PEMAZYRE 13,5 mg COMPRIMIDOS
PEMAZYRE 13,5 mg COMPRIMIDOS
Commercialized
Register Number
1211535005
Prescription Type
Uso Hospitalario
Authorization Date
May 10, 2021
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1211535005
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
PEMIGATINIBActive
Quantity: 13,5 mg
Name: PEMIGATINIB
ATC CLASSIFICATION (3)
L01E
L01EN
L01EN02